Author Archive for: muriel

About Muriel Draoui

This author has yet to write their bio.
Meanwhile lets just say that we are proud Muriel Draoui contributed a whooping 7 entries.

Entries by Muriel Draoui

Listen to Guy Sauvageau’s interview at the ESH 5th International Conference on AML

November 1, 2019 in News /by Muriel Draoui

Click on Guy Sauvageau’s interview last october on why should we target RUNX1 in AML treatment.

Vincent Lavallée’s Laboratory is joining the Leucegene group!

October 1, 2019 in News /by Muriel Draoui

Vincent will bring his expertise in single cell sequencing analysis! Positions are available in his laboratory which opened on October 2019 at CHU Sainte-Justine Research Center. Please visit www.lavalleelab.com for more details.

The Cost-effectiveness analysis of HMGA2 prognostic test for AML is now published

August 7, 2019 in News /by Muriel Draoui

Cost-effectiveness analysis of a HMGA2 prognostic test for acute myeloid leukemia in a Canadian setting is now available in Applied Health Economics and Health Policy.

Leucegene Team is now recruiting

March 12, 2018 in Recruitment /by Muriel Draoui

New publication in Blood

August 30, 2017 in News /by Muriel Draoui

H3K27M/I mutations promote context-dependent transformation in acute myeloid leukemia with RUNX1 alterations is now published in Blood.